AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6297368 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation alone for well- or moderately differentiated tumours in Stage I or IIa
Number of subjects: 142
Study 6297368 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative treatment for well differentiated, early mucinous tumours in Stage Ia
Number of subjects: 142
Study 6297368 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment for poorly differentiated tumours in Stages I and II
Number of subjects: 142
Study 30940012 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 46
Study 30940012 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) stimulation
Number of subjects: 46
Study 30940012 — intervention group
Group type: COMPARATOR
Intervention: Both groups (real and sham)
Number of subjects: 46
Study 29120984 — intervention group
Group type: COMPARATOR
Intervention: Constant load (CT) resistance training
Number of subjects: 33
Study 29120984 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyramid (PR) resistance training
Number of subjects: 33
Study 26752496 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetra-ataxiometric posturography in patients with migrainous vertigo
Number of subjects: 48
Study 26752496 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetra-ataxiometric posturography in patients with migraine without aura
Number of subjects: 48
Study 24570015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 0.15 mg/kg
Number of subjects: 36
Study 24570015 — intervention group
Group type: COMPARATOR
Intervention: Saline-only placebo
Number of subjects: 36
Study 22271004 — intervention group
Group type: EXPERIMENTAL
Intervention: Water MDCT colonography
Number of subjects: 70
Study 22271004 — intervention group
Group type: COMPARATOR
Intervention: Air MDCT colonography
Number of subjects: 70
Study 18853451 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband Imaging (NBI) laryngoscope
Number of subjects: 29
Study 17457131 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (group US)
Number of subjects: 60
Study 17457131 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulation guidance (group NS)
Number of subjects: 60
Study 15764423 — intervention group
Group type: EXPERIMENTAL
Intervention: Aftercare
Number of subjects: 194
Study 15764423 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 194
Study 15764423 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological variables and attendance at religious services
Number of subjects: 194
Study 11981600 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg methadone
Number of subjects: 0
Study 11981600 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg methadone
Number of subjects: 0
Study 11981600 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg methadone
Number of subjects: 0
Study 10321133 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8124803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography (0.84 mg/kg over 10 hours)
Number of subjects: 429
Study 8124803 — intervention group
Group type: COMPARATOR
Intervention: Exercise ECG (maximal symptom-limited bicycle test)
Number of subjects: 429
Study 8124803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography
Number of subjects: 429
Study 8124803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography and exercise ECG
Number of subjects: 429
Study 2917589 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐methoxypsoralen (5‐MOP)
Number of subjects: 11
Study 2917589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 5472756 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous heparin in a therapeutic dosage
Number of subjects: 0
Study 5472756 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31271554 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (3 g/day for 12 weeks)
Number of subjects: 130
Study 31271554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 27320903 — intervention group
Group type: EXPERIMENTAL
Intervention: ROPScore
Number of subjects: 445
Study 27320903 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP ROP
Number of subjects: 445
Study 27320903 — intervention group
Group type: EXPERIMENTAL
Intervention: WINROP
Number of subjects: 445
Study 26218818 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding with maternal holding
Number of subjects: 128
Study 26218818 — intervention group
Group type: COMPARATOR
Intervention: Maternal holding without breast-feeding
Number of subjects: 128
Study 23980090 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivanib 800 mg orally once per day plus best supportive care (BSC)
Number of subjects: 395
Study 23980090 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 395
Study 20881867 — intervention group
Group type: EXPERIMENTAL
Intervention: Different blood pressure-lowering regimens
Number of subjects: 201566
Study 20881867 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure-lowering treatments
Number of subjects: 201566
Study 20881867 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional blood pressure reduction in hypertensive patients
Number of subjects: 201566
Study 19501658 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture (TA)
Number of subjects: 0
Study 19501658 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 0
Study 16845347 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer technique
Number of subjects: 163
Study 16845347 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management
Number of subjects: 163
Study 16845347 — intervention group
Group type: COMPARATOR
Intervention: Reference arm
Number of subjects: 163
Study 12782900 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care treatment (counseling and nicotine patch therapy)
Number of subjects: 254
Study 12782900 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention (no additional treatment)
Number of subjects: 254
Study 12782900 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care treatment
Number of subjects: 254
Study 11778284 — intervention group
Group type: EXPERIMENTAL
Intervention: Total laryngectomy
Number of subjects: 423
Study 11778284 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial laryngectomy
Number of subjects: 423
Study 9084868 — intervention group
Group type: EXPERIMENTAL
Intervention: Active digital mobile radio telephone (0.05 mW/cm2)
Number of subjects: 34
Study 9084868 — intervention group
Group type: COMPARATOR
Intervention: Inactive digital mobile radio telephone (GSM) system
Number of subjects: 34
Study 7901058 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole 2 g administered 12 hours before surgery
Number of subjects: 50
Study 2419945 — intervention group
Group type: EXPERIMENTAL
Intervention: iloprost (3 infusions of 5 hours each)
Number of subjects: 33
Study 2419945 — intervention group
Group type: COMPARATOR
Intervention: iloprost (2 ng/kg/min)
Number of subjects: 33
Study 2419945 — intervention group
Group type: COMPARATOR
Intervention: PGI2 (5 ng/kg/min)
Number of subjects: 33
Study 30175373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical ripening balloon (CRB)
Number of subjects: 0
Study 30175373 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandins (PGE)
Number of subjects: 0
Study 27575731 — intervention group
Group type: EXPERIMENTAL
Intervention: rAd‐p53 transfer combined with radiotherapy (PRT)
Number of subjects: 69
Study 27575731 — intervention group
Group type: COMPARATOR
Intervention: rAd‐p53 transfer
Number of subjects: 69
Study 24928796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin 2.5 mg
Number of subjects: 8
Study 24928796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin 5 mg
Number of subjects: 8
Study 24928796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin 10 mg
Number of subjects: 8
Study 24928796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 22012969 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 2×1000 mg + MTX
Number of subjects: 755
Study 22012969 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 2×500 mg + MTX
Number of subjects: 755
Study 22012969 — intervention group
Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 755
Study 22012969 — intervention group
Group type: COMPARATOR
Intervention: Placebo + MTX
Number of subjects: 755
Study 20487584 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich beverage (test beverage)
Number of subjects: 98
Study 20487584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 18591315 — intervention group
Group type: EXPERIMENTAL
Intervention: L-isoleucine
Number of subjects: 100
Study 18591315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 18591315 — intervention group
Group type: EXPERIMENTAL
Intervention: L-isoleucine and L-valine
Number of subjects: 100
Study 18591315 — intervention group
Group type: EXPERIMENTAL
Intervention: L-valine
Number of subjects: 100
Study 18591315 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of L-isoleucine and L-valine
Number of subjects: 100
Study 15967450 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 microg of intravaginal misoprostol
Number of subjects: 114
Study 15967450 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 microg of intravaginal misoprostol
Number of subjects: 114
Study 12429856 — intervention group
Group type: EXPERIMENTAL
Intervention: High AGE diet (H-AGE)
Number of subjects: 24
Study 12429856 — intervention group
Group type: EXPERIMENTAL
Intervention: Low AGE diet (L-AGE)
Number of subjects: 24
Study 10518249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND) 200 mg/I.M. weekly for six months
Number of subjects: 33
Study 10518249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND)
Number of subjects: 33
Study 10518249 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (rHuEPO) continued
Number of subjects: 33
Study 7488444 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (100 mg over three hours)
Number of subjects: 37
Study 7488444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 7488444 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (1.5 MU over 60 minutes)
Number of subjects: 37
Study 1785705 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 ml of a 0.5% bupivacaine solution
Number of subjects: 30
Study 1785705 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml of a 0.125% bupivacaine solution in normal saline
Number of subjects: 30
Study 6920253 — intervention group
Group type: EXPERIMENTAL
Intervention: Pereflat (3 tablets daily for 3 days)
Number of subjects: 50
Study 6920253 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 tablets daily for 3 days)
Number of subjects: 50
Study 31974282 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access
Number of subjects: 312
Study 31974282 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access
Number of subjects: 312
Study 30591959 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine alone (arm B)
Number of subjects: 69
Study 30591959 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine plus all-trans-retinoic acid (arm C)
Number of subjects: 69
Study 30591959 — intervention group
Group type: COMPARATOR
Intervention: Observation (arm A)
Number of subjects: 69
Study 27984535 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin-B hemoperfusion
Number of subjects: 213
Study 27984535 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 213
Study 26112091 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel, cisplatin and 5‐fluorouracil induction chemotherapy followed by carboplatin concurrent chemoradiotherapy
Number of subjects: 36
Study 26112091 — intervention group
Group type: COMPARATOR
Intervention: conventional concurrent chemoradiotherapy
Number of subjects: 36
Study 23760634 — intervention group
Group type: EXPERIMENTAL
Intervention: Life‐Steps program
Number of subjects: 168
Study 23760634 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 168
Study 20603439 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant cisplatin-based chemotherapy
Number of subjects: 57
Study 19710081 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (5 to 6 grams, three exposures per day from chewing gum or candies)
Number of subjects: 0
Study 19710081 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of xylitol (from toothpaste studies)
Number of subjects: 0
Study 19710081 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol as a sweetener in low amounts in foods
Number of subjects: 0
Study 18318099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium salicylate iontophoresis
Number of subjects: 20
Study 18318099 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy and regular medications
Number of subjects: 20
Study 15965673 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.18% sodium hyaluronate (SH)
Number of subjects: 22
Study 15965673 — intervention group
Group type: COMPARATOR
Intervention: 1% carboxymethylcellulose (CMC)
Number of subjects: 22
Study 11988609 — intervention group
Group type: EXPERIMENTAL
Intervention: High systolic blood pressure (SBP)
Number of subjects: 17398
Study 11988609 — intervention group
Group type: EXPERIMENTAL
Intervention: Low systolic blood pressure (SBP)
Number of subjects: 17398
Study 11988609 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic intracranial hemorrhage
Number of subjects: 17398
Study 9534826 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive clinical case management (ICM)
Number of subjects: 70
Study 9534826 — intervention group
Group type: COMPARATOR
Intervention: Standard community care (control)
Number of subjects: 70
Study 7625342 — intervention group
Group type: EXPERIMENTAL
Intervention: 3870-kJ (925-kcal)/d diet for the first 16 weeks
Number of subjects: 66
Study 7625342 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced-deficit diet of 5029-6279 kJ (1200-1500 kcal)/d thereafter
Number of subjects: 66
Study 1978212 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine (less than or equal to 3 g/day)
Number of subjects: 95
Study 1978212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 226841 — intervention group
Group type: EXPERIMENTAL
Intervention: Premarin tablets, 1.25 mg per day for 3 weeks
Number of subjects: 53
Study 226841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 31743566 — intervention group
Group type: EXPERIMENTAL
Intervention: Inlay bone grafting technique
Number of subjects: 16
Study 31743566 — intervention group
Group type: COMPARATOR
Intervention: Onlay bone grafting technique (control)
Number of subjects: 16
Study 28299489 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064‐nm Q‐switched neodymium‐doped yttrium aluminum garnet (Nd:YAG) laser (QSNYL)
Number of subjects: 29
Study 25839204 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day empowerment training
Number of subjects: 257
Study 25839204 — intervention group
Group type: COMPARATOR
Intervention: 4-day entrepreneurial training (control)
Number of subjects: 257
Study 23760009 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (PHRT; n = 15)
Number of subjects: 43
Study 23760009 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (PHET; n = 13)
Number of subjects: 43
Study 23760009 — intervention group
Group type: COMPARATOR
Intervention: Time-control group (PHTC; n = 15)
Number of subjects: 43
Study 21162656 — intervention group
Group type: EXPERIMENTAL
Intervention: Q‐TER (water‐soluble coenzyme Q10) for 30 days
Number of subjects: 60
Study 21162656 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E for 30 days
Number of subjects: 60
Study 21162656 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 30 days
Number of subjects: 60
Study 19487381 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib 50 mg orally once daily on a 4 weeks on, 2 weeks off dosing schedule
Number of subjects: 750
Study 19487381 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa (IFN‐alpha) 9 MU subcutaneously thrice weekly
Number of subjects: 750
Study 17185049 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemic carvedilol
Number of subjects: 0
Study 17185049 — intervention group
Group type: EXPERIMENTAL
Intervention: Enantiomers of carvedilol
Number of subjects: 0
Study 15272670 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-based objective function optimization
Number of subjects: 0
Study 15272670 — intervention group
Group type: COMPARATOR
Intervention: Initial solutions based on minimization/maximization of dose to critical structures and targets
Number of subjects: 0
Study 11384628 — intervention group
Group type: COMPARATOR
Intervention: Low-isoflavone diet (8 mg/day)
Number of subjects: 32
Study 11384628 — intervention group
Group type: EXPERIMENTAL
Intervention: High-isoflavone diet (65 mg/day)
Number of subjects: 32
Study 11384628 — intervention group
Group type: EXPERIMENTAL
Intervention: High-isoflavone diet (130 mg/day)
Number of subjects: 32
Study 8995343 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (1000 mg/day) for 4 weeks
Number of subjects: 25
Study 8995343 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 25
Study 8425703 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon alfa therapy for chronic hepatitis C
Number of subjects: 616
Study 3300755 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg orally followed at 35 min by i.v. saline
Number of subjects: 40
Study 3300755 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo followed at 35 min by i.v. diazepam 10 mg (Diazemuls)
Number of subjects: 40
Study 29744950 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored evidence-based intervention (leaflet and letter)
Number of subjects: 65
Study 29744950 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored evidence-based intervention (leaflet)
Number of subjects: 65
Study 29744950 — intervention group
Group type: COMPARATOR
Intervention: Control leaflet about ageing well
Number of subjects: 65
Study 28606084 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon (6 capsules, 3 g daily)
Number of subjects: 116
Study 28606084 — intervention group
Group type: COMPARATOR
Intervention: Wheat flour (6 capsules, 2.5 g daily)
Number of subjects: 116
Study 25641704 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 221
Study 25641704 — intervention group
Group type: COMPARATOR
Intervention: Educational Intervention (EI)
Number of subjects: 221
Study 23683393 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stretch bandages applied weekly for 2 weeks, followed by a class II elastic stocking for 2 weeks (group A)
Number of subjects: 28
Study 23683393 — intervention group
Group type: EXPERIMENTAL
Intervention: Light stocking ('liner') for 1 week followed by superimposing a second stocking for 3 weeks (group B)
Number of subjects: 28
Study 20885188 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐[nitrooxy]ethyl 2‐amino‐3‐methylbutanoate
Number of subjects: 10
Study 20885188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 18426844 — intervention group
Group type: EXPERIMENTAL
Intervention: Praneem polyherbal vaginal tablet
Number of subjects: 100
Study 18426844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 15894775 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine 600 mg orally twice daily for two days
Number of subjects: 156
Study 15894775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 15894775 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 156
Study 12629589 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10765098 — intervention group
Group type: EXPERIMENTAL
Intervention: RPLND + 2 cycles of chemotherapy (arm A)
Number of subjects: 187
Study 10765098 — intervention group
Group type: COMPARATOR
Intervention: 3-4 cycles of primary chemotherapy (arm B)
Number of subjects: 187
Study 8653870 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin T levels measured in the initial 24 hours
Number of subjects: 976
Study 8653870 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, hypertension, number of antianginal drugs, and ECG changes at rest
Number of subjects: 976
Study 1462882 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-inhibitors
Number of subjects: 0
Study 1462882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6746961 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathy algorithm
Number of subjects: 23
Study 6746961 — intervention group
Group type: COMPARATOR
Intervention: Control group of classmates
Number of subjects: 23
Study 31526916 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost standing desk
Number of subjects: 48
Study 31526916 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 29625956 — intervention group
Group type: EXPERIMENTAL
Intervention: Video consultations
Number of subjects: 36
Study 29625956 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face consultations
Number of subjects: 36
Study 26828710 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttraumatic amnesia (PTA) duration greater than 1 week
Number of subjects: 330
Study 26828710 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttraumatic amnesia (PTA) duration of 1 to 7 days
Number of subjects: 330
Study 26828710 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttraumatic amnesia (PTA) duration greater than 7 days
Number of subjects: 330
Study 23916017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT) session
Number of subjects: 104
Study 23916017 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) session
Number of subjects: 104
Study 22613054 — intervention group
Group type: COMPARATOR
Intervention: Buspirone (60 mg/day)
Number of subjects: 60